Compare Lam Research Corporation (LRCX) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lam Research Corporation vs Manulife Financial Corporation — how do they compare? Lam Research Corporation trades at $313 (market cap $389.67B), while Manulife Financial Corporation trades at $43.84 (market cap $72.68B). The key difference: Lam Research Corporation is far larger — about 5.4× Manulife Financial Corporation's market cap, and Manulife Financial Corporation pays the higher dividend (3.1%). Which is the better fit depends on your goals.
| LRCX | MFC | |
|---|---|---|
Market Cap | $389.67B | $72.68B |
Sector | Technology | Financials |
52-Week High | $433.33 | $44.77 |
52-Week Low | $97.03 | $30.06 |
Enterprise Value | $387.83B | $67.84B |
Dividend Yield | 0.33% | 3.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lam Research (LRCX) trades at $326.02, up 6.4% in 24 hours, with a bullish technical signal and strong earnings beats. The stock shows robust fundamentals with a 29.06% net income margin and 65.07% ROE in 2025, supported by positive analyst sentiment and expansion into panel-level packaging. Recent news highlights AI-driven semiconductor demand as a key growth catalyst.
Outlook remains positive given consensus price target of $397.18 and 78% buy ratings, though high P/E of 54.06 and competitive pressures from new entrants like SpaceX's Terrafab pose risks. Revenue growth to $23.2B in 2026 suggests sustained momentum, but investors should monitor execution amid industry volatility.
MFC trades at $43.88, down 0.61% on the day, with a neutral technical signal despite bullish moving averages. The company reported Q2 2026 EPS of $0.79, beating estimates, driven by 21% APE sales growth in Asia. Revenue reached $53.01B in 2025, with net income margin at 11.7%. Recent news highlights AI partnerships with Microsoft and Alibaba Cloud, enhancing operational efficiency.
Outlook is positive with 57% analyst buy ratings and a $51.50 consensus target, though premium valuation (P/E 16.57) and mixed earnings history pose risks. Strengths include robust cash flow and dividend consistency, but investors face headwinds from competitive pressures and regulatory scrutiny in Asian markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
